West Yorkshire Adult Asthma Management and Prescribing Guideline

The West Yorkshire Adult Asthma Management guideline standardises management of patients with Asthma. The aim of this Guideline is to provide patients with asthma with basic asthma care, in line with the Personal Asthma Action Plan, and monitor preventer and reliever inhaler prescribing. Key Recommendations:
  • All patients with asthma should be treated with an inhaled corticosteroid (ICS); using short acting bronchodilator (SABA) monotherapy is now outdated and no longer acceptable.
  • Review control within a maximum of 3 months of change in therapy
  • Poor asthma control - Use of reliever (including PRN doses of MART regimen) >2 times per week
  • Poor symptom control, exacerbations. More than 6 SABA prescriptions per year should prompt urgent review
  • Review inhaler technique, adherence and co-morbidity at every opportunity including prior to stepping up therapy
  • Consider stepping down treatment if asthma is well controlled
  • Ensure patient has an asthma action plan and that it is updated appropriately
 

Related Education

Launch Event: West Yorkshire Adult Asthma Management and Prescribing Guidelines

Resources

Supporting notes – Adult Asthma Guideline

© Institute of Clinical Science and Technology.

Email: support@icst.org.uk

Tel: 02920 092828